Delisting risk
PDS Biotechnology
Develops investigational immunotherapies for cancer and infectious diseases.
$0.2136
After-hours close+0.00 (+2.05%)
At close$0.2093(−3.95%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.13 | −$0.18 | −38.5% |
| May 2026 | −$0.15 | −$0.13 | +13.3% |
| Mar 2026 | −$0.20 | −$0.14 | +30.0% |
| Nov 2025 | −$0.21 | −$0.19 | +9.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Oct 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.11 | — | — | — | — | — |
| Aug 13, 2026 | −$0.13 | −$0.18 | −38.5% | — | — | — |
| May 13, 2026 | −$0.15 | −$0.13 | +13.3% | — | — | — |
| Mar 30, 2026 | −$0.20 | −$0.14 | +30.0% | — | — | — |
| Nov 13, 2025 | −$0.21 | −$0.19 | +9.5% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 13, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 27, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 28, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 18, 2021 | ||||||
| Nov 11, 2020 | ||||||
| Aug 13, 2020 | ||||||
| May 13, 2020 | ||||||
| Mar 27, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 14, 2019 | ||||||
| Feb 21, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 1, 2018 | ||||||
| May 1, 2018 | ||||||
| Mar 1, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 1, 2017 | ||||||
| May 3, 2017 | ||||||
| Mar 2, 2017 | ||||||
| Nov 1, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 3, 2016 | ||||||
| Mar 8, 2016 | ||||||
| Nov 6, 2015 | ||||||
| Oct 6, 2015 | ||||||